Skip to main content

Table 1 Baseline characteristics

From: Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

  All (n = 16) Group 1 (n = 9) Group 2 (n = 7)
Age (yr) 63 ± 10 60 ± 11 68 ± 7
Male (n,%) 11 (69 %) 4 (44 %) 5 (71 %)
Body mass index (kg/m2) 23.7 ± 2.0 23.1 ± 1.9 24.5 ± 1.9
Total cholesterol (mg/dl) 380 ± 42 394 ± 56 364 ± 51
Triglyceride (mg/dl) 95 [84–127] 95 [88–126] 91 [68–136]
HDL cholesterol (mg/dl) 46 ± 10 49 ± 14 43 ± 6
LDL cholesterol (mg/dl) 299 ± 48 309 ± 46 283 ± 48
RLP cholesterol (mg/dl) 8.9 ± 3.3 8.7 ± 3.5 9.2 ± 3.0
Hypertension (n, %) 8 (50 %) 3 (33 %) 5 (71 %)
Diabetes (n, %) 6 (38 %) 3 (33 %) 3 (43 %)
Smoking (n, %) 1 (6 %) 0 (0 %) 1 (14 %)
Coronary artery disease (n, %) 9 (56 %) 4 (44 %) 5 (71 %)
  1. RLP remnant-like particle